ESC 365 - Prophylactic combined heart failure treatment attenuates the development of doxorubicin induced systolic and diastolic dysfunction in rats

HFA Premium Access

Prophylactic combined heart failure treatment attenuates the development of doxorubicin induced systolic and diastolic dysfunction in rats

Session: Rapid Fire 1 - Basic Science

Topic: Animal models and experimentation

Speaker: Miss M. Lodi (Debrecen, HU)

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

Add to my library

About the speaker

Miss Maria Lodi

University of Debrecen, Debrecen (Hungary)

0 follower

13 more presentations in this session

Epac1-mediated RE/mitochondria interactions promotes mitochondrial Ca2+ overload and cell death during ischemia/reperfusion injury

Speaker: Miss L. Fazal (Paris, FR)

Intramyocardial delivery of mesenchymal stem cells transfected with minicircle-HIF-1a decreases LV adverse remodelling via release of cardioprotective miRNAs and pro-angiogenic factors

Speaker: Doctor E. Gara (Budapest, HU)

NPA7, an innovative multivalent designer natriuretic peptide: Co-therapy with Furosemide to mediate renoprotection in experimental ADHF

Speaker: Doctor L. Meems (Groningen, NL)

Eosinophils have an essential role in promoting a type 2 innate immune response and cardiac repair following myocardial infarction.

NADPH oxidase-4 promotes adaptive cardiac remodelling in the chronically stressed heart by driving protein O-GlcNAcylation and enhancing cardiac fatty acid oxidation

Speaker: Doctor A. Nabeebaccus (London, GB)

Access the full session

Rapid Fire 1 - Basic Science

Speakers: Miss M. Lodi, Miss L. Fazal, Doctor E. Gara, Doctor L. Meems, Doctor A. Nabeebaccus

About the event

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources